Molsidomine

This classification denotes a nitric oxide donor and vasodilator agent with the molecular formula C9H14N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D46583G77X, chemically known as sydnone imine, n-(ethoxycarbonyl)-3-(4-morpholinyl)- but generally known as molsidomine, which bears US NIH Compound Identifier 4239. European Medicines Agency schedules Molsidomine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09044MIG. World Health Organization schedules molsidomine in its Anatomical Therapeutic Chemical (ATC) Classification. MOLSIDOMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule molsidomine under HS 29349990 and SITC 51579. As of Q4 2014, MOLSIDOMINE remains the US FDA Preferred Term for this commodity. SMILES: O1CCN([N]2NOC(NC(=O)OCC)C2)CC1.